CapsoVision, Inc. (CV)

Market Closed

11 Sep, 20:00

NASDAQ (CM)

6. 54

+0.02

+0.3067%

Pre Market

6. 70

+0.16 +2.4465%

299.28M Market Cap

- P/E Ratio

- Div Yield

975 Volume

- Eps

$ 6.52

Previous Close

Investors:

Add Transaction

Day Range

6.54 6.54

Year Range

3.6 15.37

Want to track CV and more in your Portfolio? 🎯

Get Started For Free

CapsoVision, Inc. (CV) Q2 2026 Earnings Call Transcript

Seekingalpha | 4 weeks ago

CapsoVision Q2 Earnings Call Highlights

CapsoVision NASDAQ: CV reported second-quarter revenue growth as sales of its CapsoCam Plus capsule endoscopy system increased, while the company advanced its artificial intelligence software rollout and development programs for colon and upper gastrointestinal applications.

Marketbeat | 4 weeks ago

CapsoVision Q1 Earnings Call Highlights

CapsoVision NASDAQ: CV reported steady first-quarter revenue and said it continues to advance artificial intelligence and capsule endoscopy programs aimed at expanding the use of its gastrointestinal imaging platform.

Marketbeat | 3 months ago

CapsoVision, Inc. (CV) Q1 2026 Earnings Call Transcript

Seekingalpha | 3 months ago

CapsoVision, Inc. (CV) Q4 2025 Earnings Call Transcript

Seekingalpha | 5 months ago

CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus

CV seeks FDA clearance to add AI-based reading to CapsoCam Plus to boost diagnostic accuracy and streamline reviews.

Zacks | 8 months ago

Blog Affiliate Program About Terms Privacy Help Contact Us